CClinicalTrials.gg
CompletedNCT07514689Zumba and QOLUpdated Apr 9, 2026

Effect of Zumba Training on Quality of Life, Love of Life, and Psychological Resilience

An interventional study of Experimental Group and Control in Psychological Resilience, Quality of Life and Aerobic Exercise, sponsored by Gümüşhane Universıty. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Gümüşhane Universıty · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Sep 2025, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

This randomized controlled trial aimed to investigate the effects of a structured 6-week Zumba exercise program on psychological resilience, quality of life, and love of life in sedentary young adult women. Participants were randomly assigned to either a Zumba intervention group or a control group maintaining a sedentary lifestyle. Outcomes were assessed using validated psychometric scales before and after the intervention

Read the detailed description

The study was designed as a parallel-group, two-arm randomized controlled trial using a pre-test/post-test design. A total of 36 sedentary women aged 18-25 years were randomized into either a Zumba group (n=18) or a control group (n=18). The intervention consisted of a progressive Zumba training program conducted three times per week for six weeks, with each session lasting 60 minutes.

Primary outcomes included psychological resilience, assessed using the Brief Psychological Resilience Scale (BPRS), while secondary outcomes included quality of life (SF-12) and love of life (LLS). A 2×2 mixed-design ANOVA was used to analyze group-by-time interactions.

02

Conditions studied

  • Psychological Resilience
  • Quality of Life
  • Aerobic Exercise
  • Zumba Exercise

Keywords

  • Zumba
  • Psychological resilience
  • Quality of life
  • Love of life
  • Aerobic exercise
  • Randomized controlled trial
03

In context

Lead sponsor

Gümüşhane Universıty is the lead sponsor of 34 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female participants aged 18-25 years
  • Sedentary (less than 60 min/week physical activity in last 6 months)

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal injuries
  • Chronic diseases
  • Diagnosed psychological disorders
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Zumba Exercise Group

    Participants engaged in a structured Zumba exercise program for 6 weeks (3 sessions/week, 60 minutes/session). Intervention Type: Behavioral.

    Other: Experimental Group · Other: Control

  • No intervention
    Control Group

    Participants maintained their usual sedentary lifestyle with no additional exercise. Usual sedentary lifestyle with no additional exercise

Interventions

  • OtherExperimental Group

    Participants engaged in a structured Zumba exercise program for 6 weeks (3 sessions/week, 60 minutes/session).

    Also known as: Zumba exercise

  • OtherControl

    Participants maintained their usual sedentary lifestyle with no additional exercise.

    Also known as: usual sedentary lifestyle with no additional exercise

06

What researchers measure

Primary outcomes

  1. Psychological Resilience

    Measure: Brief Psychological Resilience Scale. Total scores range from 6 to 30, with higher aggregate scores reflecting a superior capacity to 'bounce back' and higher levels of psychological resilience. Time Frame: Pre-test and Post-test

    Time frame: 6 weeks

Secondary outcomes

  1. Quality of Life

    Measure: Quality of Life Scale. It is a comprehensive self-report quality of life questionnaire consisting of 12 questions that measures individuals' physical and mental health status and its impact on daily life. Components: Physical and Mental score Scores range from 0 to 100, with higher values representing superior health-related quality of life.

    Time frame: 6 Weeks

  2. Love of Life

    Measure: Love of Life Scale. Participants' general positive attitude toward life and their perceived enjoyment of living were assessed using the Love of Life Scale (LLS). This 16-item instrument comprises three distinct factors: Positive Attitude Toward Life (PAWL) (8 items; e.g., 'Life is full of pleasure'), Happy Results of Love of Life (HRLL) (4 items; e.g., 'I want a long life to realize what I hope for'), and Meaning of Life (ML) (4 items). Responses are recorded on a 5-point Likert-type scale ranging from 1 (not at all) to 5 (very much), where higher aggregate scores indicate a more profound sense of existential meaning, happiness, and a positive outlook on life.

    Time frame: 6 weeks

07

Study locations

1 site
  • Gumushane Univetsity
    Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane 29600, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared due to privacy and confidentiality concerns. The dataset contains sensitive personal and psychological information that could potentially lead to participant identification. Data may be made available upon reasonable request to the corresponding author, subject to ethical approval and data protection regulations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07514689
Lead sponsor
Gümüşhane Universıty
Responsible party
Coşkun YILMAZ (ASSOC. PROF., Gümüşhane Universıty) — Principal investigator
First posted
Apr 7, 2026
Start date
Sep 15, 2025
Primary completion
Nov 5, 2025
Completion
Nov 20, 2025
Last update
Apr 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion